MODIQUEST B.V.
ModiQuest specializes in the generation of monoclonal antibodies against difficult target antigens for R&D, diagnostic and therapeutic applications. Using its proprietary ModiFuse™ (hybridoma electrofusion), ModiSelect™ (B-cell selection) and ModiPhage™ (phage display) technologies, ModiQuest can generate very large panels of monoclonal antibodies from various backgrounds such as mouse, rat, rabbit, chicken, llama and human, as well as transgenic animals harboring the human immunoglobulin... (antibody) gene repertoire, against virtually any target. Besides antibody lead generation, ModiQuest also provides extensive antibody development and optimization procedures, such as affinity maturation, humanization, stable cell line generation and antibody production in transient and stable mammalian cell systems.
MODIQUEST B.V.
Social Links:
Industry:
Health Care Therapeutics
Founded:
2004-01-01
Status:
Active
Technology used in webpage:
SPF Google Font API Microsoft Exchange Online Amazon Office 365 Mail Google Maps Microsoft Azure DNS GoDaddy DNS GStatic Google Static Content AWS Global Accelerator
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-07-02 | Citryll | ModiQuest B.V. investment in Series B - Citryll | 18.5 M EUR |
| 2019-07-03 | Citryll | ModiQuest B.V. investment in Series A - Citryll | N/A |
More informations about "ModiQuest B.V."
ModiQuest B.V. - Crunchbase Investor Profile & Investments
ModiQuest specializes in the generation of monoclonal antibodies against difficult target antigens for R&D, diagnostic and therapeutic applications. Using its proprietary ModiFuse™ (hybridoma …See details»
Modiquest Research B.V. - Nimwegen, Netherlands - bionity.com
Here you will find Modiquest Research B.V. See the theme worlds for related content . Topic world Antibodies. Antibodies are specialized molecules of our immune system that can …See details»
ImmunoPrecise Acquires Modiquest Research BV - ImmunoPrecise …
Apr 6, 2018 ImmunoPrecise acquired ModiQuest and its sister entity, Immulease B.V. (“Immulease”), for an aggregate purchase price of €7,000,000 (C$11,200,000) (the “Purchase …See details»
ModiQuest Research B.V. - Life-Sciences-Europe.com
Jan 1, 2005 ModiQuest Research B.V. https://www.modiquestresearch.nl Founded in 2005 and located in Oss (The Netherlands), ModiQuest Research is a Dutch biotechnology company …See details»
ModiQuest Research - VentureRadar
ModiQuest Netherlands n/a ModiQuest Research is a Contract Research Organization specialized in generation of monoclonal human and animal antibodies. MQR' proprietary …See details»
ModiQuest Research B.V. - LinkedIn
ModiQuest Research B.V. | 527 followers on LinkedIn. Founded in 2004 by Dr. Jos Raats, ModiQuest Research is one of the leading custom antibody generation and development providers. ModiQuest ...See details»
ModiQuest Acquisition | ImmunoPrecise Antibodies
Victoria, British Columbia, Canada, December 7, 2017 – IMMUNOPRECISE ANTIBODIES LTD. (the “Company”) (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that it has signed a …See details»
ModiQuest B.V. - Life-Sciences-Europe.com
Feb 1, 2004 ModiQuest B.V. was founded by Jos Raats, Ger Pruijn, and Walther van Venrooij in 2004, and discovers and develops innovative therapeutic and diagnostic antibodies in cancer …See details»
ModiQuest Research 2025 Company Profile: Valuation, Investors ...
ModiQuest Research is headquartered in Oss, Netherlands. What is the size of ModiQuest Research? ModiQuest Research has 4 total employees. What industry is ModiQuest Research …See details»
ModiQuest B.V. - PharmaBoardroom
Mar 11, 2015 Address: ModiQuest B.V., Pivot Park / RE2142, Molenweg 79, 5349 AC Oss, The Netherlands. ... Fiona Carragher, Chief Policy and Research Officer at Alzheimer’s Society, …See details»
ImmunoPrecise Acquires ModiQuest Research BV - Newswire
Apr 6, 2018 ImmunoPrecise acquired ModiQuest and its sister entity, Immulease B.V. ("Immulease"), for an aggregate purchase price of €7,000,000 (C$11,200,000) (the "Purchase …See details»
ModiQuest BV - Drug pipelines, Patents, Clinical trials - Synapse
Explore ModiQuest BV with its drug pipeline, therapeutic area, technology platform, 3 news, and 1 literature. Explore ModiQuest BV with its drug pipeline, therapeutic area, technology platform, …See details»
ModiQuest - VentureRadar
ModiQuest Research is a Contract Research Organization specialized in generation of monoclonal human and animal antibodies. MQR' proprietary antigen-specific B-cell selection …See details»
ModiQuest Research BV - Ownership and Business Overview
ModiQuest Research BV is an antibody solutions company focused on the next generation of technology behind therapeutic antibody discovery. ModiQuest Research is based in Oss City, …See details»
ModiQuest B.V. - LinkedIn
ModiQuest B.V. is activily looking for partners to co-develop or outlicense several therapeutic leads for Rheumatoid Arthritis. Current leads: -anti inflammatory fully human antibody family ...See details»
ModiQuest Research B.V.|Tokyo Future Style, Inc.
ModiQuest Research B.V. ModiQuest Research B.V. Founded in 2004, ModiQuest Research is one of the leading custom antibody generation and development providers. ModiQuest …See details»
ModiQuest Research B.V. - Company Profile & Staff Directory
Founded in 2004 by Dr. Jos Raats, ModiQuest Research is one of the leading custom antibody generation and development providers. ModiQuest Research specializes in the generation of …See details»
Deal for ModiQuest | ImmunoPrecise Antibodies
Mar 16, 2018 Victoria, British Columbia, Canada, March 16, 2018 – IMMUNOPRECISE ANTIBODIES LTD.(the “Company” or “ImmunoPrecise”) (TSX VENTURE: IPA)(OTC PINK: …See details»
ImmunoPrecise Acquires ModiQuest Research BV
Apr 6, 2018 ("ImmunoPrecise" or the "Company") (TSX VENTURE: IPA)(OTC PINK: IPATF) is pleased to announce that it has acquired all of the issued and outstanding shares of …See details»
ModiQuest - Products, Competitors, Financials, Employees, …
Citryll was founded by ModiQuest B.V., originator of the tACPA patents, Helmuth van Es, CEO Citryll, and Renato Chirivi of ModiQuest B.V., CSO Citryll and co-inventor of tACPA. About …See details»